Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Boehringer Ingelheim
Boehringer Ingelheim
Activities:
Manufacturing
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
G-CON launches "floorlessPOD" prefabricated cleanroom
The global cleanroom provider has launched its newest innovative prefabricated cleanroom structure that comes without an integrated floor
Thermo Fisher Scientific opens sterile drug facility in Asia
The global company has built a new manufacturing facility and expanded capabilities in Singapore to enable the country’s science and technology sector to accelerate research,...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Regulatory
Novatek requalifies as Boehringer Ingelheim approved supplier
The company’s products are designed to assist in managing critical aspects of a quality-controlled environment
Design & Build
Boehringer Ingelheim opens Respimat plant in Catalonia
Facility in Sant Cugat, 30-minute drive northwest of Barcelona, will produce 25 million units per year; more than half the annual global Respimat sales
Drug Delivery
Boehringer announces multimillion-dollar investment to expand oral solid dosage production in Mexico
Cash injection to increase exports of anti-diabetic drugs to the US, Argentina, Colombia and Brazil
Manufacturing
Boehringer completes €105 million expansion for respiratory pipeline
Investment at sites in Dortmund and Ingelheim boost production capacity as next-gen inhaler Respimat hits the European market
Finance
Boehringer to sell Malgrat Pharma
Japanese glass manufacturing company AGC in talks to acquire the Barcelona-based synthetic API manufacturer
Finance
Boehringer Ingelheim to invest €65 million in high-tech building
Investment will see the German pharmaceutical group build a 1,000 sq m of cleanroom space for formulating and distributing avian vaccines
Analysis
Novatek to work on automating EM program for Boehringer Ingelheim
The research-driven pharmaceutical company has decided to go with a dedicated solution for its environmental monitoring needs
Subscribe now